Amedeo Smart

Free Medical Literature Service

 

Amedeo

Parkinson's Disease
  Free Subscription

Articles published in
Neurology
    May 2024
  1. RUS T, Cuderman A, Georgiev D
    Parkinsonism Associated With Traumatic Hemorrhage in Substantia Nigra: Role of Presynaptic Dopaminergic Imaging.
    Neurology. 2024;102:e209384.
    >> Share

  2. DOPPLER CEJ, Seger A, Farrher E, Regio Brambilla C, et al
    Glutamate Signaling in Patients With Parkinson Disease With REM Sleep Behavior Disorder.
    Neurology. 2024;102:e209271.
    >> Share

    April 2024
  3. BROWN G, De Jesus S
    Bridging the Gap: Local Field Potentials Offer a Peek Into the Brain of a Person With Parkinson Disease.
    Neurology. 2024;102:e209283.
    >> Share

  4. ZHAO Y, Lai Y, Konijnenberg H, Huerta JM, et al
    Association of Coffee Consumption and Prediagnostic Caffeine Metabolites With Incident Parkinson Disease in a Population-Based Cohort.
    Neurology. 2024;102:e209201.
    >> Share

  5. ZHANG D, Zhou L, Lu C, Feng T, et al
    Free-Water Imaging of the Nucleus Basalis of Meynert in Patients With Idiopathic REM Sleep Behavior Disorder and Parkinson Disease.
    Neurology. 2024;102:e209220.
    >> Share

    March 2024
  6. PARNETTI L, Paoletti FP
    Fluid Biomarkers for Trial Enrichment and Effect Monitoring in Disease-Modifying Treatments for Parkinson Disease.
    Neurology. 2024;102:e209194.
    >> Share

  7. HUTCHISON RM, Fraser K, Yang M, Fox T, et al
    Cinpanemab in Early Parkinson Disease: Evaluation of Biomarker Results From the Phase 2 SPARK Clinical Trial.
    Neurology. 2024;102:e209137.
    >> Share

    February 2024
  8. TURNER RS
    Screening for Cognitive Decline in Isolated/Idiopathic REM Sleep Behavior Disorder: Which Test Is Best?
    Neurology. 2024;102:e208097.
    >> Share

  9. TOSIN MH, Goetz CG, Stebbins GT
    Patient With Parkinson Disease and Care Partner Perceptions of Key Domains Affecting Health-Related Quality of Life.
    Neurology. 2024;102:e208028.
    >> Share

  10. COUSINS KAQ, Irwin DJ, Tropea TF, Rhodes E, et al
    Evaluation of ATN(PD) Framework and Biofluid Markers to Predict Cognitive Decline in Early Parkinson Disease.
    Neurology. 2024;102:e208033.
    >> Share

  11. RAHAYEL S, Postuma R, Baril AA, Misic B, et al
    (99m)Tc-HMPAO SPECT Perfusion Signatures Associated With Clinical Progression in Patients With Isolated REM Sleep Behavior Disorder.
    Neurology. 2024;102:e208015.
    >> Share

    January 2024
  12. KAHLON S, Barton CR, Abu Libdeh A, O'Malley JA, et al
    Emerging Subspecialties: Pediatric Movement Disorders Neurology.
    Neurology. 2024;102:e208050.
    >> Share

    December 2023
  13. ELLIOTT JE, Bryant-Ekstrand MD, Keil AT, Ligman BR, et al
    Frequency of Orthostatic Hypotension in Isolated REM Sleep Behavior Disorder.
    Neurology. 2023;101:e2545-e2559.
    >> Share

  14. ISHIKAWA K
    How Certain Are You When Making the Diagnosis of Multiple System Atrophy?
    Neurology. 2023;101:1081-1082.
    >> Share

    November 2023
  15. PURNER D, Hormozi M, Weiss D, Barbe MT, et al
    Nationwide Retrospective Analysis of Combinations of Advanced Therapies in Patients With Parkinson Disease.
    Neurology. 2023 Nov 1:10.1212/WNL.0000000000207858.
    >> Share

    October 2023
  16. KRZYZANOWSKI B, Nielsen SS, Turner JR, Racette BA, et al
    Fine Particulate Matter and Parkinson Disease Risk Among Medicare Beneficiaries.
    Neurology. 2023 Oct 30:10.1212/WNL.0000000000207871.
    >> Share

  17. DARWEESH SK, Burke JF, Peters S
    Air Pollution and Parkinson Disease: Increasing Our Risk Each Breath We Take?
    Neurology. 2023 Oct 30:10.1212/WNL.0000000000207972.
    >> Share

  18. ROMANOWSKA J, Bjornevik K, Cortese M, Tuominen JA, et al
    Association Between Use of Any of the Drugs Prescribed in Norway and the Subsequent Risk of Parkinson Disease: A Drug-wide Association Study.
    Neurology. 2023 Oct 10:10.1212/WNL.0000000000207899.
    >> Share

  19. BEAUCHAMP LC, Dore V, Villemagne VL, Xu S, et al
    Utilizing (18)F-AV-133 VMAT2 PET Imaging to Monitor Progressive Nigrostriatal Degeneration in Parkinson Disease.
    Neurology. 2023 Oct 10:10.1212/WNL.0000000000207748.
    >> Share

    August 2023
  20. RAMATCHANDIRANE B, Rebello A, Syamala DD, Ganne P, et al
    Bilateral Iris Atrophy in a Patient With Parkinsonism.
    Neurology. 2023 Aug 30:10.1212/WNL.0000000000207743.
    >> Share

  21. KOSKA V, Albrecht P
    Inner Retinal Thickness Changes in Prevalent and Incident Parkinson Disease: A Potential Biomarker With Prognostic Value?
    Neurology. 2023 Aug 21:10.1212/WNL.0000000000207780.
    >> Share

  22. WAGNER SK, Romero-Bascones D, Cortina-Borja M, Williamson DJ, et al
    Retinal Optical Coherence Tomography Features Associated With Incident and Prevalent Parkinson Disease.
    Neurology. 2023 Aug 21:10.1212/WNL.0000000000207727.
    >> Share

  23. ALTAMIMI R, Aldhalaan H, Tous E, Nicolas-Jilwan M, et al
    Teaching NeuroImages: The Putaminal Eye, A Highly Characteristic Imaging Feature of MEGDEL Syndrome.
    Neurology. 2023 Aug 21:10.1212/WNL.0000000000207823.
    >> Share

  24. PARNETTI L, Bellomo G
    Advances in Diagnosis and Prognosis of Parkinson Disease: Value of Cerebrospinal Fluid Proteomics.
    Neurology. 2023 Aug 16:10.1212/WNL.0000000000207724.
    >> Share

  25. TSUKITA K, Sakamaki-Tsukita H, Kaiser S, Zhang L, et al
    High-Throughput CSF Proteomics and Machine Learning to Identify Proteomic Signatures for Parkinson Disease Development and Progression.
    Neurology. 2023 Aug 16:10.1212/WNL.0000000000207725.
    >> Share

  26. FRANKLIN GL
    A Letter From a Wise Man With Parkinson Disease.
    Neurology. 2023 Aug 1:10.1212/WNL.0000000000207660.
    >> Share

    July 2023
  27. CAMICIOLI RM, Colosimo C
    Neuropsychiatric Symptoms and Parkinson Disease: Are We Looking Carefully Enough?
    Neurology. 2023 Jul 31:10.1212/WNL.0000000000207722.
    >> Share

  28. LEE YG, Park M, Jeong SH, Baik K, et al
    Association of Neuropsychiatric Symptom Profiles With Cognitive Decline in Patients With Parkinson Disease and Mild Cognitive Impairment.
    Neurology. 2023 Jul 31:10.1212/WNL.0000000000207623.
    >> Share

  29. BENARROCH E
    What Is the Role of the Intralaminar Thalamic Input to the Striatum and Its Potential Implications in Parkinson Disease?
    Neurology. 2023;101:118-123.
    >> Share

  30. AGRAWAL S, Leurgans SE, Nag S, Oveisgharan S, et al
    Effects of Cerebrovascular and Lewy Body Pathology on Parkinsonian Signs in Community-Dwelling Older Adults.
    Neurology. 2023 Jul 12:10.1212/WNL.0000000000207497.
    >> Share

    June 2023

  31. Cutaneous alpha-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease.
    Neurology. 2023 Jun 30:10.1212/WNL.0000000000207614.
    >> Share

  32. NELSON PT, Jicha GA
    Surprising Synergy Between Cerebrovascular and Lewy Body Disease in Parkinsonism.
    Neurology. 2023 Jun 21:10.1212/WNL.0000000000207572.
    >> Share

  33. ZHANG Y, Zhang Y, Mao C, Jiang Z, et al
    Association of Cortical Gyrification With Imaging and Serum Biomarkers in Patients With Parkinson Disease.
    Neurology. 2023 Jun 2:10.1212/WNL.0000000000207410.
    >> Share

    May 2023
  34. WANG L, Zhou C, Zhang W, Zhang M, et al
    Association of Cortical and Subcortical Microstructure with Clinical Progression and Fluid Biomarkers in Patients With Parkinson Disease.
    Neurology. 2023 May 18:10.1212/WNL.0000000000207408.
    >> Share

  35. PORTUGAL B, Artaud F, Degaey I, Roze E, et al
    Association of Physical Activity and Parkinson Disease in Women: Long-term Follow-up of the E3N Cohort Study.
    Neurology. 2023 May 17:10.1212/WNL.0000000000207424.
    >> Share

  36. CHAHINE LM, Darweesh SKL
    Physical Activity and the Risk of Parkinson Disease: Moving in the Right Direction.
    Neurology. 2023 May 17:10.1212/WNL.0000000000207527.
    >> Share

  37. IRANZO A, Mammana A, Munoz-Lopetegi A, Dellavalle S, et al
    Misfolded alpha-Synuclein Assessment in the Skin and CSF by RT-QuIC in Isolated REM Sleep Behavior Disorder.
    Neurology. 2023;100:e1944-e1954.
    >> Share

    April 2023
  38. BRUMM MC, Pierz KA, Lafontant DE, Caspell-Garcia C, et al
    Updated Percentiles for the University of Pennsylvania Smell Identification Test in Adults 50 Years of Age and Older.
    Neurology. 2023;100:e1691-e1701.
    >> Share

  39. PARNETTI L, Bellomo G
    On the Track of alpha-Synuclein in the Body: Skin Biopsies for Diagnosing Synucleinopathies?
    Neurology. 2023;100:691-692.
    >> Share

  40. DI LUCA DG, Luo S, Liu H, Cohn M, et al
    Racial and Ethnic Differences in Health-Related Quality of Life for Individuals with Parkinson Disease Across Centers of Excellence.
    Neurology. 2023 Apr 5:10.1212/WNL.0000000000207247.
    >> Share

    February 2023
  41. REYNOLDS EL, Gallagher G, Hill CE, Banerjee M, et al
    Costs and Utilization of New-to-Market Neurologic Medications.
    Neurology. 2023;100:e884-e898.
    >> Share

  42. BECKER S, Bode M, Liepelt-Scarfone I
    Author Response: Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson Disease: A Longitudinal Cohort Study.
    Neurology. 2023;100:400.
    >> Share

  43. KASTEN M
    Reader Response: Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson Disease: A Longitudinal Cohort Study.
    Neurology. 2023;100:399-400.
    >> Share

  44. LEWIS A, Ganesh A, Galetta S
    Editors' Note: Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson Disease: A Longitudinal Cohort Study.
    Neurology. 2023;100:399.
    >> Share

    January 2023
  45. GIBBONS C, Wang N, Rajan S, Kern D, et al
    Cutaneous alpha-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease.
    Neurology. 2023 Jan 19:10.1212/WNL.0000000000206772.
    >> Share

  46. MORO E, Romito LM
    Unilateral Focused Ultrasound Subthalamotomy for Parkinson Disease: Long-term Efficacy and Safety.
    Neurology. 2023 Jan 11:10.1212/WNL.0000000000206896.
    >> Share

  47. MARTINEZ-FERNANDEZ R, Natera-Villalba E, Manez Miro JU, Rodriguez-Rojas R, et al
    Prospective Long-term Follow-up of Focused Ultrasound Unilateral Subthalamotomy for Parkinson Disease.
    Neurology. 2023 Jan 11:10.1212/WNL.0000000000206771.
    >> Share

    December 2022
  48. BOCK MA, Vittinghoff E, Bahorik AL, Leng Y, et al
    Cognitive and Functional Trajectories in Older Adults With Prediagnostic Parkinson Disease.
    Neurology. 2022 Dec 29:10.1212/WNL.0000000000206762.
    >> Share

  49. BARRIO IR, Miki Y, Jaunmuktane ZT, Warner T, et al
    Association Between Orthostatic Hypotension and Dementia in Patients With Parkinson Disease and Multiple System Atrophy.
    Neurology. 2022 Dec 16:10.1212/WNL.0000000000201659.
    >> Share

  50. PALMA JA, Cortelli P
    Blood Pressure and Risk of Dementia in Parkinson Disease and Multiple System Atrophy: Should You Buy the Dip in Such a Volatile Market?
    Neurology. 2022 Dec 16:10.1212/WNL.0000000000206803.
    >> Share

    November 2022

  51. Impulsivity Trait Profiles in Patients With Cerebellar Ataxia and Parkinson Disease.
    Neurology. 2022 Nov 29:10.1212/WNL.0000000000201691.
    >> Share

    October 2022
  52. KIM R, Choi S, Byun K, Kang N, et al
    Association of Early Weight Change With Cognitive Decline in Patients With Parkinson Disease.
    Neurology. 2022 Oct 19. pii: WNL.0000000000201404.
    >> Share

  53. ALDRIDGE CM
    Low Glucocerebrosidase Activity Predicts Dementia in Parkinson Disease: Less Is Not More!
    Neurology. 2022 Oct 18. pii: WNL.0000000000201575.
    >> Share

  54. FREQUIN HL, Schouten J, Verschuur CVM, Suwijn SR, et al
    Levodopa Response in Patients With Early Parkinson Disease: Further Observations of the LEAP Study.
    Neurology. 2022 Oct 17. pii: WNL.0000000000201448.
    >> Share

  55. OFTEDAL L, Maple-Grodem J, Dalen I, Tysnes OB, et al
    Association of CSF Glucocerebrosidase Activity With the Risk of Incident Dementia in Patients With Parkinson Disease.
    Neurology. 2022 Oct 17. pii: WNL.0000000000201418.
    >> Share

  56. KIM R, Lee TL, Lee H, Ko DK, et al
    Effects of Exercise on Depressive Symptoms in Patients With Parkinson Disease: A Meta-analysis.
    Neurology. 2022 Oct 11. pii: WNL.0000000000201453.
    >> Share

  57. PRASUHN J, Gottlich M, Ebeling B, Kourou S, et al
    Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31P-MRSI.
    Neurology. 2022 Oct 4. pii: WNL.0000000000201288.
    >> Share

  58. CHUNG SJ, Kim YJ, Kim YJ, Lee HS, et al
    Association Between White Matter Networks and the Pattern of Striatal Dopamine Depletion in Patients With Parkinson Disease.
    Neurology. 2022 Oct 4. pii: WNL.0000000000201269.
    >> Share

  59. PORTUGAL B, Artaud F, Domenighetti C, Roze E, et al
    Body Mass Index, Abdominal Adiposity, and Incidence of Parkinson Disease in French Women From the E3N Cohort Study.
    Neurology. 2022 Oct 3. pii: WNL.0000000000201468.
    >> Share

    September 2022
  60. SIEGLER JE 3RD, Galetta S
    Editors' Note: Association of Statins With Cerebral Atherosclerosis and Incident Parkinsonism in Older Adults.
    Neurology. 2022;99:585.
    >> Share

  61. OVEISGHARAN S, Bennett DA, Buchman AS
    Author Response: Association of Statins With Cerebral Atherosclerosis and Incident Parkinsonism in Older Adults.
    Neurology. 2022;99:586.
    >> Share

  62. KELLER DL
    Reader Response: Association of Statins With Cerebral Atherosclerosis and Incident Parkinsonism in Older Adults.
    Neurology. 2022;99:585.
    >> Share

  63. SASAKI R, Morimoto S, Ozawa F, Okano H, et al
    APOE Alleles With Tau and Abeta Pathology In Patients With Amyotrophic Lateral Sclerosis and Parkinsonism-Dementia Complex in the Kii Peninsula.
    Neurology. 2022 Sep 21. pii: WNL.0000000000201156.
    >> Share

  64. MAJBOUR N, Aasly J, Abdi I, Ghanem S, et al
    Disease-Associated alpha-Synuclein Aggregates as Biomarkers of Parkinson Disease Clinical Stage.
    Neurology. 2022 Sep 12. pii: WNL.0000000000201199.
    >> Share

  65. BECKER S, Bode M, Brockmann K, Gasser T, et al
    Cognitive-Driven Activities of Daily Living Impairment as a Predictor for Dementia in Parkinson Disease: A Longitudinal Cohort Study.
    Neurology. 2022 Sep 2. pii: WNL.0000000000201201.
    >> Share

    August 2022
  66. ZHANG Y, He X, Mo C, Liu X, et al
    Association Between Microbial Tyrosine Decarboxylase Gene and Levodopa Responsiveness in Patients With Parkinson Disease.
    Neurology. 2022 Aug 31. pii: WNL.0000000000201204.
    >> Share

  67. LEWIS A, Galetta S
    Editors' Note: Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
    Neurology. 2022;99:403.
    >> Share

  68. TSUKITA K, Sakamaki-Tsukita H, Takahashi R
    Author Response: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease.
    Neurology. 2022;99:402.
    >> Share

  69. BRENNER SR
    Reader Response: Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
    Neurology. 2022;99:403.
    >> Share

  70. LEWIS A, Galetta S
    Editors' Note: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease.
    Neurology. 2022;99:401.
    >> Share

  71. GRIPPE TC, Marras C, Rafferty M, Lang AE, et al
    Reader Response: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease.
    Neurology. 2022;99:401-402.
    >> Share

  72. LIN CH, Chen SJ, Kuo CH
    Author Response: Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Patients With Parkinson Disease.
    Neurology. 2022;99:404.
    >> Share

  73. TOSSERAMS A, Keijsers N, Kapelle W, Kessels RPC, et al
    Evaluation of Compensation Strategies for Gait Impairment in Patients With Parkinson Disease.
    Neurology. 2022 Aug 25. pii: WNL.0000000000201159.
    >> Share

  74. SAUNDERS-PULLMAN R, Ortega RA, Wang C, Raymond D, et al
    Association of Olfactory Performance With Motor Decline and Age at Onset in People With Parkinson Disease and the LRRK2 G2019S Variant.
    Neurology. 2022;99:e814-e823.
    >> Share

  75. CROTTY GF, Schwarzschild MA
    What to Test in Parkinson Disease Prevention Trials? Repurposed, Low-Risk, and Gene-Targeted Drugs.
    Neurology. 2022;99.
    >> Share

  76. MOLSBERRY SA, Hughes KC, Schwarzschild MA, Ascherio A, et al
    Who to Enroll in Parkinson Disease Prevention Trials? The Case for Composite Prodromal Cohorts.
    Neurology. 2022;99.
    >> Share

  77. MIRELMAN A, Siderowf A, Chahine L
    Outcome Assessment in Parkinson Disease Prevention Trials: Utility of Clinical and Digital Measures.
    Neurology. 2022;99.
    >> Share

  78. SEIBYL JP, Kuo P
    What Is the Role of Dopamine Transporter Imaging in Parkinson Prevention Clinical Trials?
    Neurology. 2022;99.
    >> Share

  79. MACKLIN EA, Coffey CS, Brumm MC, Seibyl JP, et al
    Statistical Considerations in the Design of Clinical Trials Targeting Prodromal Parkinson Disease.
    Neurology. 2022;99.
    >> Share

  80. POSTUMA RB
    Neuroprotective Trials in REM Sleep Behavior Disorder: The Way Forward Becomes Clearer.
    Neurology. 2022;99.
    >> Share

  81. BERG D, Crotty GF, Keavney JL, Schwarzschild MA, et al
    Path to Parkinson Disease Prevention: Conclusion and Outlook.
    Neurology. 2022;99.
    >> Share

  82. NIOTIS K, West AB, Saunders-Pullman R
    Who to Enroll in Parkinson Disease Prevention Trials? The Case for Genetically At-Risk Cohorts.
    Neurology. 2022;99.
    >> Share

  83. JANSSEN DAALEN JM, Schootemeijer S, Richard E, Darweesh SKL, et al
    Lifestyle Interventions for the Prevention of Parkinson Disease: A Recipe for Action.
    Neurology. 2022;99.
    >> Share

  84. GROVER S, Kumar Sreelatha AA, Pihlstrom L, Domenighetti C, et al
    Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease: Evidence From the COURAGE-PD Consortium.
    Neurology. 2022;99:e698-e710.
    >> Share

  85. CROTTY GF, Keavney JL, Alcalay RN, Marek K, et al
    Planning for Prevention of Parkinson Disease: Now Is the Time.
    Neurology. 2022;99.
    >> Share

  86. PALMA JA
    Reader Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial.
    Neurology. 2022;99:260.
    >> Share

  87. KANG UJ, Nakamura K, Zhuang X
    Reader Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial.
    Neurology. 2022;99:258-259.
    >> Share

  88. CHRISTINE CW, Richardson RM, Van Laar A, Fine EM, et al
    Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial.
    Neurology. 2022;99:260-261.
    >> Share

  89. CHRISTINE CW, Richardson RM, Fine EM, Khwaja OS, et al
    Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial.
    Neurology. 2022;99:259.
    >> Share

  90. SIEGLER JE, Galetta S
    Editors' Note: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial.
    Neurology. 2022;99:258.
    >> Share

  91. BELLOMO G, De Luca CMG, Paoletti FP, Gaetani L, et al
    alpha-Synuclein Seed Amplification Assays for Diagnosing Synucleinopathies: The Way Forward.
    Neurology. 2022;99:195-205.
    >> Share

    July 2022
  92. TSUKITA K, Sakamaki-Tsukita H, Takahashi R
    Author Response: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease.
    Neurology. 2022;99:132.
    >> Share

  93. LEWIS A, Galetta S
    Editors' Note: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease.
    Neurology. 2022;99:131.
    >> Share

  94. DARWEESH SKL, De Vries N, Bloem BR
    Reader Response: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease.
    Neurology. 2022;99:131-132.
    >> Share

  95. GUPTA VK
    Reader Response: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease.
    Neurology. 2022;99:133.
    >> Share

  96. TSUKITA K, Sakamaki-Tsukita H, Takahashi R
    Author Response: Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease.
    Neurology. 2022;99:133-134.
    >> Share

  97. TAKEUCHI H, Masaki K, Ogata H, Nagata S, et al
    Teaching NeuroImages: Reversible Parkinsonism Caused by Lumboperitoneal Shunt Overdrainage.
    Neurology. 2022 Jul 8. pii: WNL.0000000000200994.
    >> Share

    June 2022
  98. BERGQUIST F, Ehrnebo M, Nyholm D, Johansson A, et al
    Pharmacokinetics of Intravenously (DIZ101), Subcutaneously (DIZ102), and Intestinally (LCIG) Infused Levodopa in Advanced Parkinson Disease.
    Neurology. 2022 Jun 15. pii: WNL.0000000000200804.
    >> Share

  99. YOON EJ, Lee JY, Kim H, Yoo D, et al
    Brain Metabolism Related to Mild Cognitive Impairment and Phenoconversion in Patients With Isolated REM Sleep Behavior Disorder.
    Neurology. 2022;98:e2413-e2424.
    >> Share

  100. WANG L, Wu P, Brown P, Zhang W, et al
    Association of Structural Measurements of Brain Reserve With Motor Progression in Patients With Parkinson Disease.
    Neurology. 2022 Jun 6. pii: WNL.0000000000200814.
    >> Share

    May 2022
  101. TALMAN L
    Quality of Life for Patients With Parkinson Disease.
    Neurology. 2022;98:e2293-e2295.
    >> Share

  102. GROVER S, Ashwin AKS, Pihlstrom L, Domenighetti C, et al
    Genome-wide Association and Meta-analysis of Age-at-Onset in Parkinson Disease: Evidence From COURAGE-PD Consortium.
    Neurology. 2022 May 26. pii: WNL.0000000000200699.
    >> Share

  103. AVENALI M, Vaghi G, De Icco R, Grillo V, et al
    Pearls & Oy-sters: Marionette walk in Parkinson's disease: a rare dyskinetic-dystonic gait pattern complication improved by visual cueing.
    Neurology. 2022 May 18. pii: WNL.0000000000200714.
    >> Share

    April 2022
  104. LIN J, Li C, Shang H
    Teaching Video NeuroImage: Oculogyric Crises in a 12-Year-Old Girl With Rapid-Onset Dystonia Parkinsonism.
    Neurology. 2022 Apr 28. pii: WNL.0000000000200584.
    >> Share

  105. DELGADO-ALVARADO M, Gutierrez-Gonzalez A, Marques-Llano S, Riancho J, et al
    Parkinsonism Associated With Striatal Enlarged Perivascular Spaces.
    Neurology. 2022 Apr 28. pii: WNL.0000000000200547.
    >> Share

  106. CHEN TX, Roy Lin CY, Aumann MA, Yan Y, et al
    Impulsivity Trait Profiles in Patients With Cerebellar Ataxia and Parkinson Disease.
    Neurology. 2022 Apr 15. pii: WNL.0000000000200349.
    >> Share

  107. MYERS PS, O'Donnell JL, Jackson JJ, Lessov-Schlaggar CN, et al
    Proteinopathy and Longitudinal Cognitive Decline in Parkinson Disease.
    Neurology. 2022 Apr 13. pii: WNL.0000000000200344.
    >> Share

  108. BOCK MA, Brown EG, Zhang L, Tanner C, et al
    Association of Motor and Nonmotor Symptoms With Health-Related Quality of Life in a Large Online Cohort of People With Parkinson Disease.
    Neurology. 2022 Apr 13. pii: WNL.0000000000200113.
    >> Share

  109. HALLOWAY S, Desai P, Beck T, Aggarwal N, et al
    Association of Neurofilament Light With the Development and Severity of Parkinson Disease.
    Neurology. 2022 Apr 13. pii: WNL.0000000000200338.
    >> Share

    March 2022
  110. OVEISGHARAN S, Yu L, Barnes LL, Agrawal S, et al
    Association of Statins With Cerebral Atherosclerosis and Incident Parkinsonism in Older Adults.
    Neurology. 2022 Mar 23. pii: WNL.0000000000200182.
    >> Share

    February 2022
  111. GONCALVES A, Oliveira J, Simoes R, Canas N, et al
    Hemiparkinsonism Secondary to Giant Aneurysm.
    Neurology. 2022;98:325-326.
    >> Share

  112. CHUNG SJ, Kim YJ, Jung JH, Lee HS, et al
    Association Between White Matter Connectivity and Early Dementia in Patients With Parkinson Disease.
    Neurology. 2022 Feb 21. pii: WNL.0000000000200152.
    >> Share

  113. ARMENTEROS PR, Kapetanovic S, Lopez SG, Vazquez-Lorenzo E, et al
    Pearls & Oy-sters: Arteriovenous Malformation With Sinus Thrombosis and Thalamic Hemorrhage: Unusual Cause of Parkinsonism and Dementia.
    Neurology. 2022 Feb 4. pii: WNL.0000000000200016.
    >> Share

    January 2022
  114. ZHANG X, Molsberry SA, Yeh TS, Cassidy A, et al
    Intake of Flavonoids and Flavonoid-Rich Foods, and Mortality Risk Among Individuals With Parkinson Disease: A Prospective Cohort Study.
    Neurology. 2022 Jan 26. pii: WNL.0000000000013275.
    >> Share

  115. PAAKINAHO A, Koponen M, Tiihonen M, Kauppi M, et al
    Disease-Modifying Antirheumatic Drugs and Risk of Parkinson Disease: Nested Case-Control Study of People With Rheumatoid Arthritis.
    Neurology. 2022 Jan 21. pii: WNL.0000000000013303.
    >> Share

  116. MAK MK, Schwarz HB
    Could Exercise Be the Answer? Disease-Modification With Long-term Regular Physical Activity in Parkinson Disease.
    Neurology. 2022 Jan 12. pii: WNL.0000000000013208.
    >> Share

  117. TSUKITA K, Sakamaki-Tsukita H, Takahashi R
    Long-term Effect of Regular Physical Activity and Exercise Habits in Patients With Early Parkinson Disease.
    Neurology. 2022 Jan 12. pii: WNL.0000000000013218.
    >> Share

  118. PROVITERA V, Iodice V, Manganelli F, Mozzillo S, et al
    Postganglionic Sudomotor Assessment in Early Stage of Multiple System Atrophy and Parkinson Disease: A Morpho-functional Study.
    Neurology. 2022 Jan 11. pii: WNL.0000000000013300.
    >> Share

  119. CHEN SJ, Chen CC, Liao HY, Lin YT, et al
    Association of Fecal and Plasma Levels of Short-Chain Fatty Acids With Gut Microbiota and Clinical Severity in Parkinson Disease Patients.
    Neurology. 2022 Jan 7. pii: WNL.0000000000013225.
    >> Share

  120. HWANG YJ, Alexander GC, Moore TJ, Mehta HB, et al
    Author Response: Risk of Hospitalization and Death Associated With Pimavanserin Use in Older Adults With Parkinson Disease.
    Neurology. 2022;98:49-50.
    >> Share

  121. SUBBIAH P, Doshi D, Turner ME
    Reader Response: Risk of Hospitalization and Death Associated With Pimavanserin Use in Older Adults With Parkinson Disease.
    Neurology. 2022;98:49.
    >> Share

  122. GANESH A, Galetta S
    Editors' Note: Risk of Hospitalization and Death Associated With Pimavanserin Use in Older Adults With Parkinson Disease.
    Neurology. 2022;98:48.
    >> Share

    December 2021
  123. MAIDAN I, Hacham R, Galperin I, Giladi N, et al
    Neural Variability in the Prefrontal Cortex as a Reflection of Neural Flexibility and Stability in Patients With Parkinson Disease.
    Neurology. 2021 Dec 14. pii: WNL.0000000000013217.
    >> Share

    November 2021
  124. PRINGSHEIM T, Day GS, Smith DB, Rae-Grant A, et al
    Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee.
    Neurology. 2021;97:942-957.
    >> Share

    October 2021
  125. RONG S, Xu G, Liu B, Sun Y, et al
    Trends in Mortality From Parkinson Disease in the United States, 1999-2019.
    Neurology. 2021 Oct 27. pii: WNL.0000000000012826.
    >> Share

  126. BESSE-PINOT E, Pereira B, Durif F, Fantini ML, et al
    Preoperative REM Sleep Behavior Disorder and Subthalamic Deep Brain Stimulation Outcome in Parkinson Disease 1 Year After Surgery.
    Neurology. 2021 Oct 19. pii: WNL.0000000000012862.
    >> Share

  127. YOON SY, Park YH, Lee HJ, Kang DR, et al
    Lifestyle Factors and Parkinson Disease Risk: Korean Nationwide Cohort Study With Repeated Health Screening Data.
    Neurology. 2021 Oct 14. pii: WNL.0000000000012942.
    >> Share

  128. CHRISTINE CW, Richardson RM, Van Laar AD, Thompson ME, et al
    Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial.
    Neurology. 2021 Oct 14. pii: WNL.0000000000012952.
    >> Share

  129. RUSZ J, Tykalova T, Novotny M, Zogala D, et al
    Defining Speech Subtypes in De Novo Parkinson Disease: Response to Long-term Levodopa Therapy.
    Neurology. 2021 Oct 4. pii: WNL.0000000000012878.
    >> Share

    September 2021
  130. SAMOTUS O, Chen R, Jog M
    Changes in Cortical Excitability and Parkinson Tremor After Botulinum Toxin Therapy.
    Neurology. 2021 Sep 8. pii: WNL.0000000000012662.
    >> Share

  131. TOSSERAMS A, Wit L, Sturkenboom IHWM, Nijkrake MJ, et al
    Perception and Use of Compensation Strategies for Gait Impairment by Persons With Parkinson Disease.
    Neurology. 2021 Sep 8. pii: WNL.0000000000012633.
    >> Share

  132. HANTIKAINEN E, Trolle Lagerros Y, Bonn S
    Author Response: Dietary Antioxidants and the Risk of Parkinson Disease: The Swedish National March Cohort.
    Neurology. 2021;97:511-512.
    >> Share

  133. KAWADA T
    Reader Response: Dietary Antioxidants and the Risk of Parkinson Disease: The Swedish National March Cohort.
    Neurology. 2021;97:511.
    >> Share

  134. MATAR E, White SR, Taylor JP, Thomas A, et al
    Progression of Clinical Features in Lewy Body Dementia Can Be Detected Over 6 Months.
    Neurology. 2021;97:e1031-e1040.
    >> Share

  135. CHIEN HF, Rodriguez RD, Bonifati V, Nitrini R, et al
    Neuropathologic Findings in a Patient With Juvenile-Onset Levodopa Responsive Parkinsonism Due to ATP13A2 Mutation.
    Neurology. 2021 Sep 2. pii: WNL.0000000000012705.
    >> Share

    August 2021

  136. PARK2, PINK1, and DJ1 in patients with early-onset Parkinson's disease in four European countries.
    Neurology. 2021 Aug 31. pii: WNL.0000000000012715.
    >> Share

  137. PILOTTO A, Romagnolo A, Scalvini A, Masellis M, et al
    Association of Orthostatic Hypotension With Cerebral Atrophy in Patients With Lewy Body Disorders.
    Neurology. 2021;97:e814-e824.
    >> Share

  138. HWANG YJ, Alexander GC, An H, Moore TJ, et al
    Risk of Hospitalization and Death Associated With Pimavanserin Use in Older Adults With Parkinson Disease.
    Neurology. 2021 Aug 13. pii: WNL.0000000000012601.
    >> Share

  139. ALI F
    Pimavanserin: A Friend or Foe in Parkinson Disease Psychosis.
    Neurology. 2021 Aug 13. pii: WNL.0000000000012656.
    >> Share

  140. CHOU KL, Martello J, Atem J, Elrod M, et al
    Quality Improvement in Neurology: 2020 Parkinson Disease Quality Measurement Set Update.
    Neurology. 2021;97:239-245.
    >> Share

    June 2021
  141. PRASUHN J, Prasuhn M, Fellbrich A, Strautz R, et al
    Association of Locus Coeruleus and Substantia Nigra Pathology With Cognitive and Motor Functions in Patients With Parkinson Disease.
    Neurology. 2021 Jun 29. pii: WNL.0000000000012444.
    >> Share


  142. Cross-Sectional Profile of Most Bothersome Problems as Reported Directly by Individuals With Parkinson's Disease (2697).
    Neurology. 2021 Jun 22. pii: WNL.0000000000012412.
    >> Share

  143. BOVE F, Mulas D, Cavallieri F, Castrioto A, et al
    Long-term Outcomes (15 Years) After Subthalamic Nucleus Deep Brain Stimulation in Patients With Parkinson Disease.
    Neurology. 2021 Jun 2. pii: WNL.0000000000012246.
    >> Share

    May 2021
  144. GANDHI AB, Onukwugha E, Albarmawi H, Johnson A, et al
    Healthcare Resource Utilization Associated With Parkinson Disease Among Medicare Beneficiaries.
    Neurology. 2021 May 27. pii: WNL.0000000000012290.
    >> Share

  145. SHIN JH, Lee JY, Kim YK, Yoon EJ, et al
    Parkinson Disease-Related Brain Metabolic Patterns and Neurodegeneration in Isolated REM Sleep Behavior Disorder.
    Neurology. 2021 May 19. pii: WNL.0000000000012228.
    >> Share

  146. BEACH T, Chahine LM, Adler CH, Mollenhauer B, et al
    Author Response: In Vivo Distribution of alpha-Synuclein in Multiple Tissues and Biofluids in Parkinson Disease.
    Neurology. 2021;96:965-967.
    >> Share

  147. GIBBONS C, Donadio V, Sommer C, Liguori R, et al
    Reader Response: In Vivo Distribution of alpha-Synuclein in Multiple Tissues and Biofluids in Parkinson Disease.
    Neurology. 2021;96:964-965.
    >> Share

  148. IRWIN D, Saint-Hilaire M
    In Vivo Detection of Underlying Synucleinopathies: Are We There Yet?
    Neurology. 2021;96:925-926.
    >> Share

  149. DONADIO V, Wang Z, Incensi A, Rizzo G, et al
    In Vivo Diagnosis of Synucleinopathies: A Comparative Study of Skin Biopsy and RT-QuIC.
    Neurology. 2021;96:e2513-e2524.
    >> Share

  150. MCCUSKER EA, Loy CT
    Prevalent Nonmotor Symptoms Associated With Huntington Disease: Challenging to Interpret and With Early Impact on Function.
    Neurology. 2021;96:875-876.
    >> Share

  151. KIM R, Park S, Yoo D, Jun JS, et al
    Association of Physical Activity and APOE Genotype With Longitudinal Cognitive Change in Early Parkinson Disease.
    Neurology. 2021;96:e2429-e2437.
    >> Share

  152. HONG Z, Tian C, Stewart T, Aro P, et al
    Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying alpha-Synuclein-Containing Extracellular Vesicles.
    Neurology. 2021;96:e2332-e2345.
    >> Share

    April 2021
  153. RIOU A, Houvenaghel JF, Dondaine T, Drapier S, et al
    Functional Role of the Cerebellum in Parkinson Disease: A PET Study.
    Neurology. 2021 Apr 28. pii: WNL.0000000000012036.
    >> Share

  154. DONG Y, Cheng X, Dong Q
    Teaching NeuroImages: Parkinsonism Presenting With Watershed Pattern Lesions.
    Neurology. 2021 Apr 26. pii: WNL.0000000000012056.
    >> Share

  155. LAMOTTE G, Benarroch EE
    What Is the Clinical Correlation of Cardiac Noradrenergic Denervation in Parkinson Disease?
    Neurology. 2021;96:748-753.
    >> Share

    March 2021
  156. RABER J, Darweesh SKL, Savica R
    Physical Activity May Reduce Apolipoprotein E4-Associated Cognitive Decline in Parkinson Disease.
    Neurology. 2021 Mar 31. pii: WNL.0000000000011851.
    >> Share

  157. TANG X, Zhang Y, Liu D, Hu Y, et al
    Association of Gyrification Pattern, White Matter Changes, and Phenotypic Profile in Patients With Parkinson Disease.
    Neurology. 2021 Mar 25. pii: WNL.0000000000011894.
    >> Share

  158. HACKER ML, Konrad PE, Davis TL, Charles D, et al
    Author Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes.
    Neurology. 2021;96:592.
    >> Share

  159. SIDIROPOULOS C
    Reader Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes.
    Neurology. 2021;96:591-592.
    >> Share

  160. CHARLES D, Hacker ML, Davis TL, Konrad PE, et al
    Author Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes.
    Neurology. 2021;96:591.
    >> Share

  161. FASANO A, Bhowmick SS
    Reader Response: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes.
    Neurology. 2021;96:590-591.
    >> Share

  162. SIEGLER JE, Galetta S
    Editors' Note: Deep Brain Stimulation in Early-Stage Parkinson Disease: Five-Year Outcomes.
    Neurology. 2021;96:590.
    >> Share

  163. CHUNG SJ, Yoo HS, Shin NY, Park YW, et al
    Perivascular Spaces in the Basal Ganglia and Long-term Motor Prognosis in Newly Diagnosed Parkinson Disease.
    Neurology. 2021 Mar 2. pii: WNL.0000000000011797.
    >> Share

    February 2021
  164. LO C, Arora S, Ben-Shlomo Y, Barber TR, et al
    Olfactory Testing in Parkinson's Disease & REM Behavior Disorder: A Machine Learning Approach.
    Neurology. 2021 Feb 24. pii: WNL.0000000000011743.
    >> Share

  165. KANG X, Ploner A, Pedersen NL, Bandres-Ciga S, et al
    Tumor Necrosis Factor Inhibition and Parkinson Disease: A Mendelian Randomization Study.
    Neurology. 2021 Feb 19. pii: WNL.0000000000011630.
    >> Share

  166. PARK KW, Lee EJ, Lee JS, Jeong J, et al
    Machine Learning Based Automatic Rating for Cardinal Symptoms of Parkinson.
    Neurology. 2021 Feb 10. pii: WNL.0000000000011654.
    >> Share

  167. PARK JH, Lee CW, Nam MJ, Kim H, et al
    Association of High-density Lipoprotein Cholesterol Variability and the Risk of Developing Parkinson's Disease.
    Neurology. 2021 Feb 3. pii: WNL.0000000000011553.
    >> Share

  168. PES GM, Park YM, Sechi GP
    Cholesterol trafficking in the brain: Are we overlooking an important risk factor for Parkinson's disease?
    Neurology. 2021 Feb 3. pii: WNL.0000000000011595.
    >> Share

    January 2021
  169. HANTIKAINEN E, Lagerros YT, Ye W, Serafini M, et al
    Dietary antioxidants and the risk of Parkinson Disease: The Swedish National March Cohort.
    Neurology. 2021 Jan 6. pii: WNL.0000000000011373.
    >> Share

    December 2020

  170. Correction: Cultural disparities in deep brain stimulation (DBS) decision making in patients with Parkinson disease (PD) (1713).
    Neurology. 2020 Dec 22. pii: WNL.0000000000011240.
    >> Share

  171. MAPLE-GRODEM J, Dalen I, Tysnes OB, Macleod AD, et al
    Association of GBA Genotype with Motor and Functional Decline in Newly Diagnosed Patients with Parkinsons Disease.
    Neurology. 2020 Dec 21. pii: WNL.0000000000011411.
    >> Share

  172. SHIN JH, Lee JY, Kim YK, Shin SA, et al
    Longitudinal change in dopamine transporter availability in idiopathic REM sleep behavior disorder.
    Neurology. 2020;95:e3081-e3092.
    >> Share

  173. PYATIGORSKAYA N, Yahia-Cherif L, Valabregue R, Gaurav R, et al
    Parkinson Disease Propagation Using MRI Biomarkers and Partial Least Squares Path Modeling.
    Neurology. 2020 Dec 4. pii: WNL.0000000000011155.
    >> Share

    November 2020
  174. BECKER S, Granert O, Timmers M, Pilotto A, et al
    Association of hippocampal subfields, CSF biomarkers and cognition in non-demented Parkinson's disease patients.
    Neurology. 2020 Nov 20. pii: WNL.0000000000011224.
    >> Share

  175. HIRATA K, Yokota T, Miura Y
    Teaching-Neuroimages: Parkinsonism secondary to a metastatic lesion involving the substantia nigra.
    Neurology. 2020 Nov 9. pii: WNL.0000000000011162.
    >> Share

    October 2020
  176. WALDVOGEL D, Baumann CR
    Author response: Beware of deep water after subthalamic deep brain stimulation.
    Neurology. 2020;95:760.
    >> Share

  177. SIDIROPOULOS C
    Reader response: Beware of deep water after subthalamic deep brain stimulation.
    Neurology. 2020;95:759-760.
    >> Share

  178. WALDVOGEL D, Baumann CR
    Author response: Beware of deep water after subthalamic deep brain stimulation.
    Neurology. 2020;95:759.
    >> Share

  179. BOUCA-MACHADO R, Neves M, Pona-Ferreira F, Ferreira JJ, et al
    Reader response: Beware of deep water after subthalamic deep brain stimulation.
    Neurology. 2020;95:758-759.
    >> Share

  180. TAN AH, Lim SY, Chong KK, Azhan A Manap MA, et al
    Probiotics for constipation in Parkinson's disease: A randomized placebo-controlled study.
    Neurology. 2020 Oct 12. pii: WNL.0000000000010998.
    >> Share

  181. LIN CH, Chiu MJ
    Author response: Blood NfL: A biomarker for disease severity and progression in Parkinson disease.
    Neurology. 2020;95:658.
    >> Share

  182. VAN RUMUND A, Marques TM, Esselink RAJ, Bloem BR, et al
    Reader response: Blood NfL: A biomarker for disease severity and progression in Parkinson disease.
    Neurology. 2020;95:657-658.
    >> Share

  183. LEWIS A, Galetta S
    Editors' note: Blood NfL: A biomarker for disease severity and progression in Parkinson disease.
    Neurology. 2020;95:657.
    >> Share

  184. FRIEDMAN JH, Goetz CG
    Apathy in Parkinson's disease: Why we should care.
    Neurology. 2020 Oct 1. pii: WNL.0000000000010961.
    >> Share

  185. SCOTT BM, Eisinger RS, Burns MR, Lopes J, et al
    Co-occurrence of apathy and impulse control disorders in Parkinson's disease.
    Neurology. 2020 Oct 1. pii: WNL.0000000000010965.
    >> Share

    September 2020
  186. CROTTY GF, Maciuca R, Macklin EA, Wang J, et al
    Association of caffeine and related analytes with resistance to Parkinson's disease among LRRK2 mutation carriers: A metabolomic study.
    Neurology. 2020 Sep 30. pii: WNL.0000000000010863.
    >> Share

  187. POSTUMA RB
    Dopamine imaging in prodromal Parkinson disease trials: Ready for prime time?
    Neurology. 2020 Sep 28. pii: WNL.0000000000010957.
    >> Share

  188. CHUNG SJ, Lee HS, Kim HR, Yoo HS, et al
    Factor analysis-derived cognitive profile predicting early dementia conversion in PD.
    Neurology. 2020;95:e1650-e1659.
    >> Share

    August 2020
  189. COON EA, Mandrekar JN, Berini SE, Benarroch EE, et al
    Predicting phenoconversion in pure autonomic failure.
    Neurology. 2020;95:e889-e897.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016